Community Training - Pandemic Influenza
... 2. The virus causes disease in humans 3. The virus is easily spread between humans ...
... 2. The virus causes disease in humans 3. The virus is easily spread between humans ...
Effectiveness of Oseltamivir in Preventing Influenza in
... placebo groups were compared using x2 tests and test-based confidence intervals (CIs) adjusted to take into account the probable intracluster correlation in end point incidence.23 Other Analyses. Other analyses comparing numbers of contacts meeting a given end point used x2 tests and CIs adjusted to ...
... placebo groups were compared using x2 tests and test-based confidence intervals (CIs) adjusted to take into account the probable intracluster correlation in end point incidence.23 Other Analyses. Other analyses comparing numbers of contacts meeting a given end point used x2 tests and CIs adjusted to ...
H1N1 Global Pandemic 2009 Kevin Sherin, MD, MPH, FACPM, FAAFP Director
... The percent of emergency department visits associated with influenza-like illness is greatest in the <1-19 age group, and now exceeds the percent observed during the initial increase in May 2009. Increases since June are mostly occurring in the younger and middle age groups. ...
... The percent of emergency department visits associated with influenza-like illness is greatest in the <1-19 age group, and now exceeds the percent observed during the initial increase in May 2009. Increases since June are mostly occurring in the younger and middle age groups. ...
Pandemic Influenza (H1N1) - National Centre for Disease Control
... Students, teachers and other employees working in schools/educational institutions are advised to observe strict cough / sneeze etiquette i.e. using tissue while sneezing and coughing. The tissue paper so used should be kept in a separate plastic bag, so that it can be disposed of safely. All the sc ...
... Students, teachers and other employees working in schools/educational institutions are advised to observe strict cough / sneeze etiquette i.e. using tissue while sneezing and coughing. The tissue paper so used should be kept in a separate plastic bag, so that it can be disposed of safely. All the sc ...
Meta Analysis: Blood Products for Spanish Influenza Pneumonia: A
... those who received early treatment but also occurred in some who received late treatment. • Adverse events: The most commonly reported adverse event was a brief "chill" reaction with a transient elevation in body temperature of 1° to 2°F 30 to 120 minutes after the transfusion. Serious complications ...
... those who received early treatment but also occurred in some who received late treatment. • Adverse events: The most commonly reported adverse event was a brief "chill" reaction with a transient elevation in body temperature of 1° to 2°F 30 to 120 minutes after the transfusion. Serious complications ...
Influenza Clinical Research Solutions
... 99 A total of 332 subjects were screened; 31 were enrolled - 20 subjects met the definition of laboratory-confirmed infection (mAb, n=13; and placebo, n=7) (AR = 62%) 99 vAUC for mAb treated subjects was reduced by 92% (p=0.019); peak viral load was reduced by 2.2 logs (p=0.009) (interim result data ...
... 99 A total of 332 subjects were screened; 31 were enrolled - 20 subjects met the definition of laboratory-confirmed infection (mAb, n=13; and placebo, n=7) (AR = 62%) 99 vAUC for mAb treated subjects was reduced by 92% (p=0.019); peak viral load was reduced by 2.2 logs (p=0.009) (interim result data ...
Pandemic Influenza
... between humans • No vaccine for humans is available • Limited supply of expensive antiviral ...
... between humans • No vaccine for humans is available • Limited supply of expensive antiviral ...
Influenza factsheet schools and special schools 2014
... has to be produced to protect against the flu viruses expected to be in circulation that winter and to boost the immune response. The vaccine is very safe and side effects are uncommon and usually mild. The vaccine is given in the autumn before the flu season begins. It is not recommended for everyo ...
... has to be produced to protect against the flu viruses expected to be in circulation that winter and to boost the immune response. The vaccine is very safe and side effects are uncommon and usually mild. The vaccine is given in the autumn before the flu season begins. It is not recommended for everyo ...
Pandemic Preparedness and Awareness Course
... According to sources at Johns Hopkins Medicine, researchers believe that the contagious period for H1N1 is similar to that of the seasonal flu. The seasonal flu contagious period lasts for one day prior to the appearance of symptoms, then seven days while the individual has symptoms. This period may ...
... According to sources at Johns Hopkins Medicine, researchers believe that the contagious period for H1N1 is similar to that of the seasonal flu. The seasonal flu contagious period lasts for one day prior to the appearance of symptoms, then seven days while the individual has symptoms. This period may ...
Pulmonary Lecture Preview
... Two main parts of management of epiglottis include securing the airway and instituting antibiotics. Recommended empiric treatment includes third generation cephalosporins with clindamycin or ...
... Two main parts of management of epiglottis include securing the airway and instituting antibiotics. Recommended empiric treatment includes third generation cephalosporins with clindamycin or ...
The Public Health Agency of Canada (PHAC)
... reported of which 50% were for influenza A viruses (one A(H3) and one A(H1N1)pdm09 AKA Swine Flu!) and 50% for influenza B viruses Only 1 region reported sporadic activity (BC) in week 34. No new outbreaks of influenza/ILI were reported No influenza-associated hospitalizations were reported over ...
... reported of which 50% were for influenza A viruses (one A(H3) and one A(H1N1)pdm09 AKA Swine Flu!) and 50% for influenza B viruses Only 1 region reported sporadic activity (BC) in week 34. No new outbreaks of influenza/ILI were reported No influenza-associated hospitalizations were reported over ...
Severe acute respiratory infection caused by
... gross underestimation of the actual number as there are no typical signs and symptoms that distinguish SIV infections in humans from those caused by seasonal influenza viruses [4]. Indeed several sero-epidemiological studies suggest that SIV infection in people with occupational swine exposure is co ...
... gross underestimation of the actual number as there are no typical signs and symptoms that distinguish SIV infections in humans from those caused by seasonal influenza viruses [4]. Indeed several sero-epidemiological studies suggest that SIV infection in people with occupational swine exposure is co ...
PART I 2. “Prolonged Influenza by Mutation
... If successive mutations continue occurring with any other type of virus (avian or another of high pathogenicity), a flu virus, even more lethal, could be generated. For example, the avian flu virus could mutate or merge with the prolonged influenza virus, or the prolonged influenza by mutation virus ...
... If successive mutations continue occurring with any other type of virus (avian or another of high pathogenicity), a flu virus, even more lethal, could be generated. For example, the avian flu virus could mutate or merge with the prolonged influenza virus, or the prolonged influenza by mutation virus ...
Influenza factsheet
... circulation that winter and to boost the immune response. The vaccine is very safe and side effects are uncommon and usually mild. The vaccine is given in the autumn before the flu season begins. It is not recommended for everyone, but it is advisable for those likely to be more seriously affected b ...
... circulation that winter and to boost the immune response. The vaccine is very safe and side effects are uncommon and usually mild. The vaccine is given in the autumn before the flu season begins. It is not recommended for everyone, but it is advisable for those likely to be more seriously affected b ...
Human Viruses and Avian Antiserum | Charles River
... virus supplied by the customer. After incubating, candling to remove dead embryos and chilling, the infectious allantoic fluid (AF) is harvested from each egg. The allantoic fluid in each harvest container is then tested for sterility. The AF is then concentrated via tangential flow filtration (TFF) ...
... virus supplied by the customer. After incubating, candling to remove dead embryos and chilling, the infectious allantoic fluid (AF) is harvested from each egg. The allantoic fluid in each harvest container is then tested for sterility. The AF is then concentrated via tangential flow filtration (TFF) ...
Influenza Complications
... Influenza is a serious infectious disease that can cause severe illness in people of all ages even if they are in good health. An individual’s response to influenza is difficult to predict. Some people will experience mild symptoms, while the virus may cause serious infection or death in others. Inf ...
... Influenza is a serious infectious disease that can cause severe illness in people of all ages even if they are in good health. An individual’s response to influenza is difficult to predict. Some people will experience mild symptoms, while the virus may cause serious infection or death in others. Inf ...
Influenza Facts from
... • Vaccination is the single greatest way to prevent flu and its associated illnesses, hospitalizations and deaths. • Persons infected with flu will shed the virus for 24-48 hours prior to having symptoms. This shedding is very infectious to those around them. • A flu shot not only protects the indiv ...
... • Vaccination is the single greatest way to prevent flu and its associated illnesses, hospitalizations and deaths. • Persons infected with flu will shed the virus for 24-48 hours prior to having symptoms. This shedding is very infectious to those around them. • A flu shot not only protects the indiv ...
SEA-CD-147 Bookfold
... Presently, only oseltamivir is considered effective against all subtypes of influenza A virus and is recommended for stockpiling and use during the outbreak and to pre-empt the pandemic. However, as of 6 January 2006, oseltamivir is manufactured only by one company. The manufacturing capacity, altho ...
... Presently, only oseltamivir is considered effective against all subtypes of influenza A virus and is recommended for stockpiling and use during the outbreak and to pre-empt the pandemic. However, as of 6 January 2006, oseltamivir is manufactured only by one company. The manufacturing capacity, altho ...
PANDEMIC INFLUENZA H1N1 (Swine Flu)
... throat, and stomach problems such as nausea, vomiting, and diarrhea. Seasonal influenza can cause serious complications and on average, kills about 36,000 people in this country each year, mostly individuals over the age of 65 or children under 2. An influenza pandemic is a much more severe type of ...
... throat, and stomach problems such as nausea, vomiting, and diarrhea. Seasonal influenza can cause serious complications and on average, kills about 36,000 people in this country each year, mostly individuals over the age of 65 or children under 2. An influenza pandemic is a much more severe type of ...
Swine-origin Influenza A (H1N1) Virus: An Update
... with a clinically compatible illness who died of an unexplained acute respiratory illness (ARI) and is considered to be epidemiologically linked to a probable or confirmed case.6 A confirmed case of pandemic influenza A (H1N1) virus infection is defined as a person with an acute febrile respirator ...
... with a clinically compatible illness who died of an unexplained acute respiratory illness (ARI) and is considered to be epidemiologically linked to a probable or confirmed case.6 A confirmed case of pandemic influenza A (H1N1) virus infection is defined as a person with an acute febrile respirator ...
Swine flu - infectious diseases content sampler
... self-limited and do not require visit to a health care provider or hospitalization [16]. Patients with severe illness and those at high risk for complications from influenza should seek medical care. Those with severe illness and complications may require prolong hospitalization, and in some cases ve ...
... self-limited and do not require visit to a health care provider or hospitalization [16]. Patients with severe illness and those at high risk for complications from influenza should seek medical care. Those with severe illness and complications may require prolong hospitalization, and in some cases ve ...
1PandemicsHistory
... causes severe diarrhea leading to dehydration and death The first pandemic is characterized by the unprecedented spread of the bacteria throughout Asia, starting at the Lower Ganges River in India Total estimated deaths: 30 000 ...
... causes severe diarrhea leading to dehydration and death The first pandemic is characterized by the unprecedented spread of the bacteria throughout Asia, starting at the Lower Ganges River in India Total estimated deaths: 30 000 ...
Shionogi Presents New Clinical and Non-clinical Data on S
... treatment of influenza. S-033188 is an investigational product being developed for one-time dosing, and has the potential to be more effective than existing marketed anti-influenza products. Development and commercialization are in collaboration with F. Hoffmann-La Roche Ltd. ...
... treatment of influenza. S-033188 is an investigational product being developed for one-time dosing, and has the potential to be more effective than existing marketed anti-influenza products. Development and commercialization are in collaboration with F. Hoffmann-La Roche Ltd. ...
Oseltamivir
Oseltamivir INN /ɒsəlˈtæmɨvɪər/, marketed under the trade name Tamiflu, is an antiviral medication used to treat influenza A and influenza B (flu), and to prevent flu after exposure. The medication is taken orally.The Infectious Disease Society of America, the United States' Centers for Disease Control and Prevention (CDC), and the United Kingdom's National Institute for Health and Care Excellence recommend the use of oseltamavir for people who have complications or are at high risk for complications who present within 48 hours of first symptoms of infection. They recommend its use to prevent infection in at-risk people but not the general population. The CDC recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. However, these recommendations are controversial as are criticisms of the recommendations. A Cochrane review concluded that oseltamivir does not reduce hospitalizations, and that there is no evidence of reduction in complications of influenza (such as pneumonia) because of a lack of diagnostic definitions, or reduction of the spread of the virus. Two meta-analyses have concluded that benefits in those who are otherwise healthy do not outweigh its risks. They also found little evidence regarding whether treatment changes the risk of hospitalization or death in high risk populations. However, another meta-analysis found that oseltamivir was effective for prevention of influenza at the individual and household levels.Side effects include psychiatric symptoms, increased rates of vomiting, and headaches. It is pregnancy category C in the United States and category B in Australia meaning that it has been taken by a small number of women without signs of problems and in animal studies it looks safe. Dose adjustment may be needed in those with kidney problems.It was the first orally administered neuraminidase inhibitor commercially developed. It was discovered and developed by US-based Gilead Sciences, which licensed the exclusive rights to Roche in 1996. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.